Atlas Trials

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

Clinical trial NCT02718066 · COMPLETED

Trial details

NCT number
NCT02718066
Sponsor
HUYABIO International, LLC.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MelanomaRenal Cell CarcinomaNon-Small Cell Lung Cancer
Start date
2016-08-18
Primary completion
2023-12-12
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.